Wayland Group to Explore Strategic Alternatives to Maximize Shareholder Value Including the Spinout and/or European Listing of its International Assets

December 19, 18

TORONTO, ON, December 19, 2018 – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”), a global, vertically integrated cultivator and processor of cannabis, today announced that its Board of Directors has initiated a process to explore a broad range of strategic alternatives, including, but not limited to assessing the potential spin-out and/or European

Read More

Wayland Announces Significant Supply Agreement with RavenQuest BioMed

December 19, 18

TORONTO, ON, December 18, 2018 – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) and RavenQuest BioMed Inc. (“RavenQuest”) are pleased to announce the companies have entered into a supply agreement whereby Wayland will purchase up to 8,000 kg of dried flower cannabis from RavenQuest in 2019. The total quantity will be shipped

Read More

Wayland Group Announces Strategic Acquisition in Argentina

December 11, 18

TORONTO, ON, December 11, 2018 – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce it has entered into an agreement to purchase 819 hectares of existing developed agriculture land in San Juan Province in Argentina. San Juan Province is ideal for cannabis cultivation due to the provinces’s climate and

Read More

Wayland Enters the Asia-Pacific Market with Australian Acquisition

December 03, 18

TORONTO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce its expansion into Australia, through entering into an agreement to acquire 50.1% of Tropicann Pty Ltd. (“Tropicann”), a newly formed, privately owned Australian company located in Darwin, Northern Territory, to partner with industry leaders

Read More

Wayland Group Enters the United Kingdom

November 26, 18

TORONTO, ON, November 26, 2018 – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce it has entered into an agreement to acquire 51% of UK based Theros Pharma Ltd. ("Theros"), an early stage company that has successfully imported cannabis to the UK for patients with a prescription for medical

Read More

Wayland Group Announces Appointment of General Counsel

November 19, 18

TORONTO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce the appointment of Matthew McLeod who will assume the role of General Counsel. The Company is pleased to welcome Matthew to the newly created role. Mr. McLeod was called to the Ontario bar in

Read More

Wayland Group Announces Definitive Agreement for Italian Joint Venture

November 09, 18

TORONTO, ON, November 9, 2018 – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce it has completed a definitive joint venture agreement with CBD Italian Factory S.S., a company of Group San Martino for the production of high quality cannabis products in Italy. The joint venture will marry the

Read More

Wayland Group Announces Closing of Over-Allotment Option for Additional Gross Proceeds of $7.5 Million

November 08, 18

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, ON, November 8, 2018 – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) announced today that, further to its press release dated October 31, 2018

Read More

Wayland Group Announces Changes to the Board

November 07, 18

TORONTO, ON, November 7, 2018 – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to welcome Mr. Clay Horner and Mr. Rudolph (Rudi) Hilti to the board, which will strengthen and improve corporate governance, global strategy, finance, and M&A expertise. These latest appointments demonstrate management’s continued commitment to ensuring measured growth

Read More

Wayland Group Enters into Agreement to Expand Global Footprint with Acquisition in Colombia

November 06, 18

TORONTO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company) is pleased to announce that the Company has entered the South American market through a transaction in Colombia. Wayland has entered into a definitive agreement to acquire 100% of the outstanding shares of Colma Pharmaceutical SAS (“Colma”), a

Read More